Forian Total Cash From Operating Activities from 2010 to 2026
| FORA Stock | USD 2.08 0.01 0.48% |
Total Cash From Operating Activities | First Reported 2019-12-31 | Previous Quarter -344.5 K | Current Value -439.7 K | Quarterly Volatility 2 M |
Forian | Total Cash From Operating Activities | Build AI portfolio with Forian Stock |
Latest Forian's Total Cash From Operating Activities Growth Pattern
| Total Cash From Operating Activities | 10 Years Trend |
|
Total Cash From Operating Activities |
| Timeline |
Forian Total Cash From Operating Activities Regression Statistics
| Arithmetic Mean | -2,278,028 | |
| Coefficient Of Variation | -194.01 | |
| Mean Deviation | 2,734,951 | |
| Median | -1,032,372 | |
| Standard Deviation | 4,419,515 | |
| Sample Variance | 19.5T | |
| Range | 18M | |
| R-Value | -0.13 | |
| Mean Square Error | 20.5T | |
| R-Squared | 0.02 | |
| Significance | 0.61 | |
| Slope | -117,870 | |
| Total Sum of Squares | 312.5T |
Forian Total Cash From Operating Activities History
Stock Overview, Methodology & Data Sources
Methodology
Unless otherwise specified, financial data for Forian Inc is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Forian (USA Stocks:FORA) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: The data underlying this report is sourced from public filings and market reference sources, including filings and releases published by U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Food & Drug Administration (FDA). Some updates may be delayed based on publication cadence. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
Forian Inc is covered by 1 analyst. Representative analyst firms may include Evercore ISI, Morgan Stanley, BMO Capital Markets, Oppenheimer & Co., Guggenheim Securities, among others. Updates may occur throughout the day.
This content is curated and reviewed by:
Gabriel Shpitalnik - Member of Macroaxis Editorial BoardAlso Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.More Resources for Forian Stock Analysis
Reviewing Forian Inc commonly begins with financial statements and performance trends. Financial ratios provide context for profitability, efficiency, and growth trends. Selected reports below provide context for Forian Stock: Quarterly Earnings Growth -0.89 | Earnings Share -0.02 | Revenue Per Share | Quarterly Revenue Growth 0.656 | Return On Assets |